Argent BioPharma Says Case Study Confirms Treatment of Lennox-Gastaut Syndrome Patient with Cannabinoid-Based Formulation

MT Newswires Live

Aug 05, 2025

Argent BioPharma (ASX:RGT) said that a peer-reviewed case study was published in the International Journal of Clinical Medicine & Case Reports, covering the treatment of a pediatric patient with Lennox-Gastaut Syndrome using CannEpil, a proprietary cannabidiol/tetrahydrocannabinol isolate formulation produced by Argent, according to a Tuesday Australian bourse filing.

Per the case study, the patient experienced reduced seizure clusters and daily seizure frequency. They also experienced a recovery of speech, fine motor control, and independent mobility, as well as reintegration into a full-time educational environment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2557370753"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557370753\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557370753?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 07:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557370753","market":"nz","top_or_hot":-1,"title":"Argent BioPharma Says Case Study Confirms Treatment of Lennox-Gastaut Syndrome Patient with Cannabinoid-Based Formulation","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RGTLF\">Argent BioPharma</a> (ASX:RGT) said that a peer-reviewed case study was published in the International Journal of Clinical Medicine &amp; Case Reports, covering the treatment of a pediatric patient with <a href=\"https://laohu8.com/S/LII\">Lennox</a>-Gastaut Syndrome using CannEpil, a proprietary cannabidiol/tetrahydrocannabinol isolate formulation produced by Argent, according to a Tuesday Australian bourse filing.</p><p>Per the case study, the patient experienced reduced seizure clusters and daily seizure frequency. They also experienced a recovery of speech, fine motor control, and independent mobility, as well as reintegration into a full-time educational environment.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Argent BioPharma Says Case Study Confirms Treatment of Lennox-Gastaut Syndrome Patient with Cannabinoid-Based Formulation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArgent BioPharma Says Case Study Confirms Treatment of Lennox-Gastaut Syndrome Patient with Cannabinoid-Based Formulation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-08-05 07:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RGTLF\">Argent BioPharma</a> (ASX:RGT) said that a peer-reviewed case study was published in the International Journal of Clinical Medicine &amp; Case Reports, covering the treatment of a pediatric patient with <a href=\"https://laohu8.com/S/LII\">Lennox</a>-Gastaut Syndrome using CannEpil, a proprietary cannabidiol/tetrahydrocannabinol isolate formulation produced by Argent, according to a Tuesday Australian bourse filing.</p><p>Per the case study, the patient experienced reduced seizure clusters and daily seizure frequency. They also experienced a recovery of speech, fine motor control, and independent mobility, as well as reintegration into a full-time educational environment.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4086","symbol_name":"建筑产品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2557370753","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557370753","pubTimestamp":1754351936,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Argent BioPharma (ASX:RGT) said that a peer-reviewed case study was published in the International Journal of Clinical Medicine & Case Reports, covering the treatment of a pediatric patient with Lenno","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4086":"建筑产品","BK7096":"制药","LII":"雷诺士","RGT.AU":"Argent BioPharma Limited"},"translate_title":"Argent BioPharma表示，案例研究证实了使用大麻素制剂治疗伦诺克斯-加斯托综合征患者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGT.AU":0.9,"LII":1},"content_text":"Argent BioPharma (ASX:RGT) said that a peer-reviewed case study was published in the International Journal of Clinical Medicine & Case Reports, covering the treatment of a pediatric patient with Lennox-Gastaut Syndrome using CannEpil, a proprietary cannabidiol/tetrahydrocannabinol isolate formulation produced by Argent, according to a Tuesday Australian bourse filing.Per the case study, the patient experienced reduced seizure clusters and daily seizure frequency. They also experienced a recovery of speech, fine motor control, and independent mobility, as well as reintegration into a full-time educational environment.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}